Cardio Diagnostics CDIO, a leader in artificial intelligence-driven precision cardiovascular medicine, has published a potentially revolutionary study in the Journal of the American Heart Association ...
Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD ™, an ...
Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and early detection more precise, has ...
Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. CHICAGO, January 07, 2026--(BUSINESS WIRE)--Cardio Diagnostics ...
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) shares are trading higher Tuesday after the company announced its AI-driven molecular heart disease test has received an Innovation Technology contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results